Literature DB >> 18664944

Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans.

Antonieta Medina Lara1, Barbara Nyanzi Wakholi, Agnes Kasirye, Paula Munderi, Christine Watera, David G Lalloo, Alan Haycox, Charles F Gilks, Heiner Grosskurth.   

Abstract

OBJECTIVE: To assess the psychometric performance of using standard gamble (SG), time trade-off (TTO) and visual analogue scale (VAS) in the evaluation of three predetermined HIV/AIDS health states in HIV-infected Ugandans, for use in cost-effectiveness analyses.
METHODS: We recruited participants with CD4 cells <200/microl from the Development of AntiRetroviral Therapy in Africa (DART) trial cohort [randomized trial evaluating antiretroviral therapy (ART) management strategies] in Uganda, before they initiated ART (n = 276). A comparison group of ART-naive HIV-infected individuals was recruited from the Entebbe Cohort study (n = 159). Participants were interviewed and asked to rate his/her own health state using VAS; rank and evaluate HIV/AIDS predetermined health states using TTO and SG relative to an improved health state. Tools were tested for psychometrical properties.
RESULTS: Women constituted 64% and 76% of the DART and Entebbe Cohorts. Mean age was 36.5 and 36.7 years, respectively. Participants could discriminate between predetermined HIV/AIDS health states. Deterioration in health status was associated with a reduction in rating scores (VAS), increased willingness to give up time (TTO) and acceptance of increased risk (SG) to achieve a better health state, independent of the participant's actual health state, as measured by CD4 cell counts.
CONCLUSION: VAS, TTO and SG have good psychometric properties, making them good candidates for use in resource-constrained settings. Further research in a wider population is necessary to generate an evidence base with which to inform resource allocation decisions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664944     DOI: 10.1097/01.aids.0000327633.85221.9a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study.

Authors:  Bjarne Robberstad; Jan Abel Olsen
Journal:  Cost Eff Resour Alloc       Date:  2010-04-16

2.  Mastopexy for breast ptosis: Utility outcomes of population preferences.

Authors:  Ahmed Ms Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Mark K Markarian; Bernard T Lee; Samuel J Lin
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

3.  Patient-Proxy and Societal Perspectives of Quality-of-Life Utilities in Children With Cleft Lip and Palate Managed With Surgical Repair vs No Repair in Ethiopia.

Authors:  Karen Y Chung; Gebremedhin B Gebretekle; Andrew Howard; Eleanor Pullenayegum; Mekonen Eshete; Christopher R Forrest; Beate Sander
Journal:  JAMA Netw Open       Date:  2022-07-01

Review 4.  Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis.

Authors:  Hendramoorthy Maheswaran; Pelham Barton
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

5.  Nipple-areolar Complex Reconstruction following Postmastectomy Breast Reconstruction: A Comparative Utility Assessment Study.

Authors:  Ahmed M S Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Marc A M Mureau; Adam M Tobias; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-05-07

6.  Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.

Authors:  Alethea W McCormick; Nadia N Abuelezam; Erin R Rhode; Taige Hou; Rochelle P Walensky; Pamela P Pei; Jessica E Becker; Madeline A DiLorenzo; Elena Losina; Kenneth A Freedberg; Marc Lipsitch; George R Seage
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

Review 7.  Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis.

Authors:  Bach Xuan Tran; Long Hoang Nguyen; Arto Ohinmaa; Rachel Marie Maher; Vuong Minh Nong; Carl A Latkin
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

8.  Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.

Authors:  Louis S Matza; Karen C Chung; Katherine J Kim; Trena M Paulus; Evan W Davies; Katie D Stewart; Grace A McComsey; Marshall W Fordyce
Journal:  Qual Life Res       Date:  2017-03-24       Impact factor: 4.147

9.  Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.

Authors:  Jane Mallewa; Alexander J Szubert; Peter Mugyenyi; Ennie Chidziva; Margaret J Thomason; Priscilla Chepkorir; George Abongomera; Keith Baleeta; Anthony Etyang; Colin Warambwa; Betty Melly; Shepherd Mudzingwa; Christine Kelly; Clara Agutu; Helen Wilkes; Sanele Nkomani; Victor Musiime; Abbas Lugemwa; Sarah L Pett; Mutsa Bwakura-Dangarembizi; Andrew J Prendergast; Diana M Gibb; A Sarah Walker; James A Berkley
Journal:  Lancet HIV       Date:  2018-04-10       Impact factor: 16.070

10.  Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.

Authors:  S Boyer; M L Nishimwe; L Sagaon-Teyssier; L March; S Koulla-Shiro; M-Q Bousmah; R Toby; M P Mpoudi-Etame; N F Ngom Gueye; A Sawadogo; C Kouanfack; L Ciaffi; B Spire; E Delaporte
Journal:  Pharmacoecon Open       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.